A semisynthetic cephalosporin antibiotic which can be administered intravenously or by suppository. The drug is highly resistant to a broad spectrum of beta-lactamases and is active against a wide range of both aerobic and anaerobic gram-positive and gram-negative organisms. It has few side effects and is reported to be safe and effective in aged patients and in patients with hematologic disorders.
Cetizoxime was previously indicated for the treatment of infections due to susceptible strains of bacteria.
Soba Hospital, Khartoum, Sudan
Stay informed with timely notifications on clinical trials, regulatory changes, and research advancements related to this medication.